A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris. - Concepedia

Concepedia

Publication | Closed Access

A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.

37

Citations

0

References

2013

Year

Ma Beatrice Alora Palli, Claire Marie Reyes-Habito, Xinaida Taligare Vasconcelos Lima, Alexa B. Kimball

Abstract

3mg DRSP/ 0.02 mg EE is a safe and significantly effective treatment for moderate truncal acne.